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Role of Polyclonal Cell Activation in the
Initiation of Immune Complex-Mediated
Pulmonary Injury Following Antigen
Inhalation
by Bruce J. Shenker,* Thomas N. Mann,* and William F.
Willoughby*
The lung, by virtue ofitsanatomic situation, providesenvironmental antigenswith unique access to host
lymphoid tissues. In order to better understand the biologic consequences of antigen inhalation, we
developed an animal model in which soluble proteins are administered in aerosol form to rabbits. By
labeling these proteins withfluorochrome dyesorradioactiveisotopes, the uptake, distribution, andfateof
such proteins can be demonstrated both morphologicaily and quantitatively. Prompt host-antibody re-
sponses can be demonstrated to inhaled antigen, but not to comparable amounts of ingested antigen.
Repeated administrations of antigen aerosol to immune animals produced little injury; in contrast,
administration ofaerosols containing phytohemagglutinin or concanavalin A (Con A), plant lectinswhich
activate leucocytes in a polyclonal fashion, induced a diffuse interstitial pneumonitis. When immune
animals inhaled antigen plus Con A, devastating pulmonary necrosis was induced, in association with
localized depositsofimmunecomplexescontainingantigen,antibodyandcomplement. Suchnecroticinjury
healed by scarringwithin4 weeks. Thenecrotizinginjurycould beprevented byeither decomplementation
with cobra venom factor, or through inhibition ofleucocyte responsiveness to Con A by administration of
cholera toxin, a cAMP agonist.
Thesestudies indicatethatantigeninhalationmayserveasanimportantmeansofestablishing"natural"
immunity to environmental agents, but also may lead to severe pulmonary injury and fibrosis where the
agents inhaled act not only as antigens but as polyclonal leucocyte activators as well.
Introduction
Certain forms of environmental lung disease pro-
voked by inhaled substances are thought to result
from immunologically mediated inflammatory injury
to the pulmonary parenchyma; such diseases have
been termed "allergic alveolitis" or, alternatively,
"hypersensitivity pneumonitis." In order to better
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understand the pathogenesis of such injury, animal
models have been studied in which protein antigens,
polyclonal cell activators derived from plants, or
other organic materials have been administered in
aerosol form to normal or immune animals.
Inhalation ofbovine serum albumin (BSA), a pro-
tein antigen, causes little, if any, injury in BSA-
immunized rabbits, presumably because it does not
have access to humoral antibody (1). However, we
have observed that inhalation challenge with mix-
tures of antigen plus concanavalin A (Con A), a
polyclonal cell activator, produced a severe necro-
tizing pneumonitis in immune recipients, in associa-
tion with localized deposits ofimmune complexes of
inhaled antigen, host antibody and complement
(2, 3). We now present evidence that this enhance-
ment of immune complex formation in the lung by
April 1980 43inhaled Con A occurs as a direct consequence of
Con A's ability to stimulate lymphocytes in vivo. To
do this, we have employed purified cholera toxin
(CT), a cAMP agonist which inhibits leucocyte
stimulation by Con A in vitro.
First, we have compared three different regimens
ofin vivo CT administration for inhibition of Con A-
induced stimulation of peripheral lymphocytes in
vitro, and also for inhibition of Con A-induced in-
flammation inthe skin. We thendemonstrate thatCT
administration selectively inhibits cell-mediated,
delayed hypersensitivity skin reactions but not the
antibody-mediated vasculitis associated with the
Arthus reaction. Finally, we show that when we
block cell-mediated reactivity to Con A in vivo, we
also block the ability of Con A to trigger immune
complex reactions in the lung between inhaled anti-
gen and humoral antibody. Lastly, these inhibitory
effects of CT can be correlated with elevations in
lymphocyte cAMP concentrations associated with
CT administration.
Materials and Methods
NewZealand White malerabbitsusedinthis study
weighed 2-3 kg and were purchased from HARE
(Hare, N.J.). The rabbits were housed in laminar
flow rooms supplied with filtered air and given both
rabbit chow and water ad libitum. All animals were
immunized with BSA (Sigma, St. Louis, Mo.) incor-
porated into an alum precipitate as previously de-
scribed (1). Each rabbit received a total of 50 mg
BSA, 10 mg of protein initially, followed by 20 mg
each on days 7 and 21, injected bilaterally in four
equal parts at dorsal and gluteal sites.
Aerosols containing BSA and Con A were ad-
ministered as previously described (1). Briefly,
aerosols were generated in a DeVilbiss model 35A
ultrasonic nebulizer containing a solution of 100 mg
BSA and 100 mg Con A in 20 ml of PBS. Each
aerosol was vented into a Plexiglas chamber into
which two rabbits' heads could be inserted simul-
taneously. Each aerosol administration required ap-
proximately 60-90 min to complete, and was ad-
ministered toeach animal onthree consecutive days.
All animals were then sacrificed 24 hr after the last
aerosol by an intravenous overdose of nembutal.
Conconavalin A
Con A was prepared from Jack bean meal (Difco,
Detroit, Mich.) according to the method ofAgrawal
and Goldstein (4), modified as previously described
(3). The purified Con A gave a singleprecipitin band
by immunodiffusion in gel against rabbit anti-Jack
bean meal antibody, and a single symmetrical peak
by velocity sedimentation in a 10-40% sucrose den-
sity gradient.
Cholera Toxin
CT was purchased from Schwarz/Mann (Orange-
burg, N.Y.). It was characterized by the supplier as
giving a single band in disc electrophoresis. A 1-mg
portion of lyophilized CT was initially resuspended
in 1 ml H20, then diluted in saline to a final concen-
tration of 100 or 50 ,g/ml. Prior to injection, the
diluted CTwasfiltered through a0.22 Millipore filter
(Bedford, Mass.). In searchforoptimalconditionsof
inhibition, several different regimes of CT adminis-
trations were employed in initial studies. In some
experiments (protocol A), rabbits were injected via
the marginal earvein with40 ,ugofCT/kg, 24 hrprior
tothefirstaerosol, followed48 hrlaterwithasecond
IV injection of20 ug/kg. Inothers (protocol B), daily
injection of equal amounts were given in four con-
secutive days, beginning 24 hr prior to the first
aerosol; the total daily dosage in the latter protocol
was 80 ,g/kg body weight or approximately 160 ug/
animal. Finally, a third group ofrabbits (protocol C)
was given 40 ,ug of CT/kg IP, followed 48 hr later
with a second injection of 20 ,ug/kg.
The amounts of CT employed in these studies
were derived empirically in preliminary experi-
ments. It is apparent from such studies that the
amounts ofCT required for suppression of immune
effector reactions in vivo are near lethal values. Al-
though no rabbit died in the experiments presented
here (nor in most subsequent experiments carried
out to date), we have on occasion seen animals re-
ceiving similar amounts ofCT die within 24-48 hr of
the first injection. At autopsy, the only obvious
pathological findings in these animals was the occa-
sional presence of fluid in the pleural cavities.
Lymphocyte Cultures
Rabbitswere bledfromthe central arteryoftheear
and the peripheral lymphocytes isolated by the
method of Boyum (5). The cells were washed twice
with Hanks balanced salt solution (HBSS) (Micro-
biological Assoc., Rockville, Md.) and, ifnecessary,
any remaining red blood cells lysed with 0.84% am-
monium chloride. The lymphocytes were diluted in
culture medium to give a suspension of 2 x 106
cells/ml. The culture medium employed consisted of
RPMI 1640 (Microbiological Assoc.) containing
10mM HEPES buffer (Sigma, St. Louis, Mo.), 10%
heat inactivated pooled normal rabbit serum, 2mM
glutamine, 100 units/ml penicillin, and 100 ,g/ml
streptomycin (Microbiological Assoc.).
Equal volumes (0.1 ml each) of diluted cells (2 x
105 cells) and of medium containing Con A were
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Plastics, Cambridge, Mass.). After incubation for
52-54 hr at 37°C in humidified aircontaining 5% C02,
0.05 ml ofmedia containing 0.5 ,uCi of3H-thymidine
(specific activity = 5.0 Ci/mmole, Amersham/
Searle, Arlington Heights, Ill.) was added to each
well. After 72 hr of total incubation time, the cells
were harvested on Reeve Angel glass fiber filters
(Whatman Inc., Clifton, N.J.) with an automatic cell
harvester (Model 24V, Brandel, Rockville, Md.).
The filters were air-dried and then placed in plastic
scintillation vials (MiniVials, RPI, Rochester,
N.Y.). A 5-ml portion of scintillation fluid (4g Om-
niscient to 1 liter toluene, RPI) were added to each
vialand the samplescounted inaBeckman LS 250or
LS 7000 liquid scintillation spectrophotometer. The
degree oflymphocyte stimulation isexpressed as the
net cpm (total cpm minus cpm ofunstimulated con-
trol cultures). Data are reported as the mean oftripli-
cate cultures + standard error of the mean.
Cyclic Nucleotide Determinations
Lymphocytes were isolated from arterial blood as
described above and 0.5 ml aliquots containing 2 x
106 cells in HBSS were placed in 16 x 125 mm Pyrex
test tubes, frozen rapidly in alcohol and Dry Ice, and
then stored at -60°C. For assay, the cells were
thawed slowly, 3 ml of ice-cold acetone added, and
the cell suspension then allowed to stand for 15 min
in an ice bath. The cell suspensions were then heated
in a 60-70°C water bath for 3 min followed by cen-
trifugation at 900 g for 15 min at 2-5°C. The super-
natants were transferred to pyrex culture tubes and
lyophilized.
Radioimmunoassay (RIA) for cAMP and cGMP
was carried out under identical conditions, as previ-
ously described (6), by use of commercial reagents
(Schwarz/Mann, Orangeburg, N.Y.). Briefly, lyo-
philized samples were then resuspended in 1.0 ml of
cold (2-5°C) 0.05M sodium acetate buffer (pH 6.2)
and 0.3 ml transferred to each of two 12 x 75 mm
polypropylene culture tubes (one for cAMP and one
for cGMP), followed by the addition of 0.1 ml of
radioactive cyclic nucleotide [2-0-succinyl cyclic
AMP (orcGMP) tyrosine methyl ester (125j)] and
0.1 mlofrabbitIgGanti-cAMPoranti-cGMPtoeach
tube. Aftermixing, all RIAtubes were held at4°C for
16-20 hr followed by addition of2.5 ml of60% satu-
rated ammonium sulfate to each tube. After 30 min,
the tubes were centrifuged at 900g for 30 min at
2-5°C. The supernatants were decanted and any ex-
cess fluid removed with a cotton-tipped applicator.
The precipitate radioactivity was measured in a
Beckman 310 gamma spectrophotometer; the effi-
ciency of1251 activity measurements wasdetermined
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to be 75%. For each assay, standard curves were
constructed using known amounts ofcyclic nucleo-
tides (ranging from 0.05 to 10.0 pmole/tube). These
curves were then used to relate the amount ofcyclic
nucleotide in unknown samples as a function ofpre-
cipitated radioactivity.
Skin Tests
Rabbits were skin-tested 20-24 hr prior to sacri-
fice. All skin tests were done on the animal's left
side, which had been previously shaved. Arthus skin
tests were induced by intradermal injection of
0.05 ml of BSA dissolved in PBS at a final concen-
tration of 1 mg protein/ml. Cell-mediated inflam-
matory skin reactions were induced by intradermal
injection of 0.05 ml of Con A (200 jig Con A/ml
PBS). In some instances, where negative reactions
were anticipated, sterile india ink (1%) was added to
the Con A and BSA skin test solutions. The india ink
provided a marker for the positive identification of
noninflammatory skin test sites; by itself, the ink
caused no inflammatory response. After sacrifice,
each test site was excised and fixed in formalin for
subsequent processing for histologic examinations.
Histology
All tissue was fixed in formalin and paraffin-
embedded tissue sections stained with hematoxylin
and eosin. Lungs were inflated with isotonic buf-
fered dormalin at a hydrostatic pressure of 10 cm
H20. Sections were taken from all lobes; each sec-
tion extended from the hilar region out to the
periphery. Injury wasjudged and graded on the ex-
tent or degree of inflammatory change, and also in
terms of the presence or absence of parenchymal
necrosis.
Results
Effects of CT on Peripheral Blood
Lymphocytes (PBL)
The effects ofCT in vivo were examined by using
three alternative administrative protocols. In pro-
tocol A, a total of 60 ug CT/kg of body weight was
injected intravenously, two-thirds being given at
time 0 and the remaining one-third at 48 hr; in pro-
tocol B, a total of 80 gg CT/kg of body weight was
injected intravenously, given daily starting at time 0
asfourequallydivided doses; in protocol C, atotal of
60 ,ug CT/kgbody weight was injected intraperitone-
ally, two-thirds attime 0 and the remainingone-third
at48 hr. Peripheral blood lymphocytes were isolated
from bleedings obtained atdaily intervals, and tested
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FIGURE 1. Effects of CT administration in vivo on responsiveness of peripheral blood lymphocytes
(PBL) to stimulation in vitro by optimal concentrations ofCon A by three different protocols forCT
administration: (-) protocol A, 60 ,ug CT/kg, IV; (O) protocol B, 80 ,g CT/kg, IV; (A) protocol C,
60 jig CT/kg, IP. Results are plotted as percent of 3HtdR incorporation observed prior to CT
administrations (time = 0), as observed in PBLobtained 24, 48, 72, and 96 hrfollowingthe initial CT
injection. Each point represents the mean vlaue observed, using triplicate assays, in each of three
animals; vertical bars express the standard error.
for their ability to incorporate 3H-TdR when stimu-
lated with Con A in vitro.
All animals given CT intravenously showed adrop
in PBL responsiveness within 24 hr following the
initial injection (Fig. 1). Animals treated with CT via
protocols A or B (intravenously) showed over a90%
inhibition in proliferative responses to Con A, and
remained unresponsive throughout the remainderof
the experiment. Onthe otherhand, administrationof
CT via the intraperitoneal route was notably less
effective, in terms of both the rapidity of onset as
well as the extent of inhibition observed.
Effects of CT Administration on
Con A-Induced Cutaneous Inflammation
The ability of Con A to activate T-lymphocytes
(and basophils) has been demonstrated in vivo as
well as in vitro; intradermal injections of Con A
induce a diffuse, local inflammatory reaction, pre-
dominantly mononuclear in character, and resem-
bling the classic tuberculin-type, delayed hypersen-
sitivity reaction (7-9). Therefore, we examined the
ability of CT to inhibit Con A-induced cutaneous
inflammation, as might be expected if CT inhibited
leucocyte activation in vivo as well as in vitro.
Con A (10 ug) was injected at duplicate sites in
rabbits receiving CT according to protocols A (three
animals), B (three animals) or C (three animals), and
also into non-CT treated controls (three animals).
Both schedules ofintravenous CT administration (A
and B) effectively inhibited the Con A-induced in-
flammatory response (Fig. 2), whereas intraperito-
neal administration gave little, if any, inhibition
(Table 1). These results paralleled those obtained in
the preceding experiment, again indicating that,
whereas intravenous administration of CT effec-
tively blocked in vivo the lymphocyte's responsive-
ness to Con A, intraperitoneal administration was
decidedly less effective. Based on these observa-
tions, protocol A was employed in subsequent expe-
riments.
Differential Effects of CT Administration
on Delayed Hypersensitivity and Immune
Complex Reactions in the Skin
The direct active Arthus reaction, induced by in-
jecting antigen intradermally into an actively im-
munized animal, consists in part of a necrotizing
vasculitis mediated by immune complexes of anti-
gen, antibody and complement, localized within the
vessel wall, and, in part, of a diffuse cutaneous
leucocytic infiltrate (similar to that produced by Con
A) considered to represent adelayed-type hypersen-
sitivity response (10). Importantly, the vasculitis
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FIGURE 2. Local inflammatory response to intraderma! injections of Con A in the rabbit: (a) diffuse
inflammatory infiltrate observed in the collagenous dermis of a normal rabbit 24 hr following
injection of 10 AgCon A (x 155); (b) absence ofany inflammatory reaction 24 hrfollowing injection
of 10 ,ug Con A in a CT-treated rabbit (protocol A). The black particulate material present in the
center ofthe field is sterile india ink which had been admixed with the Con A in order to positively
identify the injection site (x 155).
April 1980 47Table 1. Effects of CT administration on Con A-induced
cutaneous inflammation.
Rabbit CT administration Skin test grade
no. protocols (duplicate sites)a
293 (A) 40 ,ug/kg IV, day 0, + ++
294 20 ug/kg, 48 hr later + 0
295 + 0
296 (B) 20 ,ugtkg IV, daily 0 0
297 for 4 days + 0
298 0 0
299 (C)40,ug/kgIP, day0, +++ ++
300 20 ,ug/kg, 48 hr later +++ ++
288 +++ +++
249 None ++++ ++
251 +++ ++++
252 ++++ ++++
alntensity of inflammation graded from 0 (no inflammation) to
++++ (extensive inflammation).
Table 2. Differential effects of CT administration on delayed
hypersensitivity and immune complex reactions in the skin.a
Arthus reaction
Total CT, (50 ,ug BSA) Delayed
,ug/kg, hyper-
Rabbit body Diffuse sensitivity
no. weight Vasculitis inflammation (10,ugConA)
133 0 ++++ ++++ ++++
134 0 ++++ ++ ++++
138 0 +++++ +++ ++++
140 0 +++ ++ +++
135 60 ++++ 0 ++
136 60 ++++ 0 ++
137 60 ++++ 0 ++
139 60 +++++ 0 0
141 60 ++++ 0 +
alntensity of inflammation graded from 0 (no inflammation) to
+ + + + + (extensive inflammation).
does not require participation by sensitized T-lym-
phocytes, but instead is mediated by immune com-
plexes, together with homocytotropic antibodies
which participate in initiation ofcomplex formation,
and neutrophils which respond to the complement-
mediated chemotactic stimulus (10). Thus, it can be
readily produced in animals immunized passively
with antibody alone.
Using both the BSA-induced Arthus reaction (in
BSA-immunized rabbits) as well as the Con A skin
test, we were thus able to compare the effects ofCT
administration upon an immune complex-mediated
vasculitis with its effects upon delayed-type hyper-
sensitivity reactions.
As in the previous experiment, intravenous ad-
ministration of CT inhibited the inflammatory re-
sponse to Con A (Table 2). Of particular interest,
however, was its effect upon the active Arthus reac-
tion, where it inhibited the diffuse inflammatory or
delayed hypersensitivity component of the Arthus,
but not the immune complex-mediated vasculitis
(Fig. 3). Thus, these findings argue eloquently for
a selective inhibitory effect by CT upon effector
lymphocytes of the delayed-type hypersensitivity
reaction, while leaving simple immune-complex
mediated reactions intact.
Effects ofCT upon the Immunologic Pulmo-
nary Injury Associated with Inhalation of
Antigen plus a Polyclonal Cell Activator
We have recently reported that polyclonal cell
activators such as Con A and phytohemagglutinin
induce a diffuse interstitial pneumonitis when in-
haled in aerosol form (2). More importantly, they
also exert a pronounced enhancing effect upon im-
mune complex injury involving inhaled antigen,
humoral antibody and complement; such injury is
severe and is characterized by foci of frank paren-
chymal necrosis (3). We have proposed that this
enhancement may be mediated, at least in part,
through polyclonal activation of leucocytes within
the lung by Con A, leading in turn to the interstitial
inflammation typically observed following inhala-
tion of Con A (3). In particular, Con A is known to
cause T-lymphocytes to release vascular permeabil-
ity factors (11) in vitro, and to cause mast cells and
basophils to release vasoactive amines in vitro (12);
inhaled Con A could presumably be having the same
effect on these cells in vivo. In any event, inhaled
Con A might alter the cellular barriers which nor-
mally isolate intra-alveolar antigen from humoral
antibody and complement. Ifthis hypothesis is true,
then administration of CT should block both Con
A-induced interstitial pulmonary inflammation and
immune-complex mediated parenchymal necrosis,
even though, as seen in the preceding experiment,
CT has no apparent effect on simple immune com-
plex-mediated reactions such as the Arthus vascu-
litis.
The BSA-immunized rabbits were divided into
two groups of five each; one group was given CT
intravenously, according to protocol A; the other
group did not receive CT but served as acontrol. All
animals were challenged with Con A/BSA aerosols
at 24, 48, and 72 hr following the initial CT injection
and were sacrificed at96 hr. Histologicexaminations
of lung tissues revealed that both the extent and
severity ofinflammation were greatly reduced in the
CT-treated animals as compared to the controls
(Fig. 4). Of particular importance was the striking
reduction in the incidence of immune-complex type
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FIGURE 3. Directactive Arthusreaction toBSAinjected intradermally intoaBSA-immunized rabbit: (a)
Arthus reaction in a control animal; notice both the necrotizing vasculitis (mediated by immune
complexes containing BSA, anti-BSA antibody and complement) and the diffuse inflammatory
infiltrate (representing a delayed hypersensitivity reaction to BSA) (x 155); (b) direct active Arthus
reaction in a rabbit treated with CT. An intense necrotizing vasculitis is still seen, but the diffuse
inflammatory component is notably reduced (x 155).
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FIGURE 4. Pulmonary injury following administration of BSA/Con A aerosols to BSA-immunized
rabbits: (a) severe interstitial pneumonitis with areas of frank parenchymal necrosis in a control
animal notgivenCT(x 60); (b) inhibitionofpulmonary injury inaCT-treated animal. A smallfocusof
interstitial inflammation is seen in the right upper corner (x 60).
Environmental Health Perspectives 50Table 3. CT-Induced suppression of immunologic pulmonary injury in BSA-immunized rabbits challenged with BSA/Con A aerosol.a
CT, Ag/kg Lung injuryb Lymphocyte
Rabbit body cAMP,
no. weight MeLa RUL RML RLLh RLLP LUL LLLh LLLP pmole/106 cells
131 0 0 1+++ + 0 ++ 0
133 0 0 0 J ++ + + 0 0
134 0 + ++++ + 0 J++++ 0 0 7.0+ 1.2
138 0 +++ ±+++++ ++ ++ +++++ + °
140 0 0 + 0 ++++ [ +
135 60 + 0 ++ 0 0 + 0 0
136 60 0 0 + ++ 0 0 ND 0
137 60 ++++± ++ ++++ ++ 0 ++++ + 0 18.6 ± 2.4
139 60 + 0 + 0 + 0 + 0 p = 0.002
141 60 0 0 ++ 0 0 +++ 0 0
aLesions gradedfrom0(noinjury)to + ++++ (severe injury). Lobescontainingone ormorefoci ofparenchymal necrosisare enclosed
in boxes. ND = not examined.
bSites ofinjury: MeL = mediastinal lobe; RUL = right upperlobe; RML = right middle lobe; RLLh = hilarportion ofright lower lobe;
RLLp = peripheral portion ofright lowerlobe; LUL = left upperlobe; LLLh = hilar portionofleftlowerlobe; LLLp = peripheral portion
of left lower lobe.
necrosis, with such lesions being observed in only
two lobes from a single animal receiving CT,
whereas such lesions were present in a total of 14
lobes of the control group, with all animals being
affected (Table 3).
In vitro studies have shown CT to act through
adenylate cyclase to increase cellular cAMP levels.
In order to look for a similar effect in vivo, we
obtained daily bleedings from the five rabbits re-
ceiving CT via schedule A, as well as from the five
controls, harvested the lymphocytes and measured
their cAMP levels by radioimmunoassay (Table 3).
The average cAMP concentration in cells obtained
following the initial CT injection was 18.6 +
2.4 pmole/l106 cells, significantly greater than that in
cells from control animals (7.0 + 1.2 pmoles/106
cells, p = 0.002).
In some cases, different experimental observa-
tions were carried out simultaneously in the same
animals, thereby providing a form ofinternal control
and underscoring the mutual relevance ofthe differ-
ent phenomena. For example, the selective action of
CT upon cell-mediated versus antibody-mediated
reactions in the skin, its effects on Con A/BSA
aerosol challenge, and on cAMP levels in peripheral
blood lymphocytes, were performed simultaneously
in animals 131-141 (see Tables 2 and 3). Thus, obser-
vations that CT treatment was able to block the
immune complex-mediated parenchymal necrosis,
but not the Arthus vasculitis, were made simultane-
ously in individual CT-treated animals.
Discussion
We have previously proposed that inhaled poly-
clonal cell activators enhance local immune complex
injury, in an indirect fashion, through their ability to
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stimulate pulmonary lymphocytes. These activated
lymphocytes could then "trigger" immune complex
formation between intra-alveolar antigen and hu-
moral antibody by releasing lymphokine mediators
or, possibly, through direct cell-cell cytotoxic reac-
tions. This hypothesis has been critically tested in
this study by examining whether selective inhibition
of lymphocyte responses to Con A in vivo in fact
blocked not only cell-mediated interstitial lung in-
jury, but immune complex-mediated parenchymal
necrosis as well.
To achieve such a selective inhibition in vivo, we
elected to use CT for several reasons. First, the
ability ofCTtoinhibitlymphocyte effectorfunctions
in vitro through its actions as a cAMPagonist is now
well documented (13, 14). Moreover, wefavored CT
over other known cAMP agonist since it binds irre-
versibly to cell membranes, and its cAMP stimulat-
ing effects are notably prolonged relative to those of
the beta adrenergic stimulators (15). In addition,
Warren and colleagues (16) had previously reported
that CT, when administered intravenously to mice,
inhibited cell-mediated inflammatory responses to
schistosome egg antigen, in association with a
doubling of spleen cell cAMP content.
As a first step, we demonstrated that CT adminis-
tration could inhibit peripheral blood lymphocytes.
Lymphocytes harvested from CT-treated animals
were shown to have impaired proliferative responses
when treated with optimal concentrations ofCon A
in vitro, and the local in vivo inflammatory response
to intradermal injections of Con A was also sup-
pressed. Second, we showed that the effect ofCT on
immune effector responses was selective, by dem-
onstrating that it inhibited both the cell-mediated
response to Con A and the classic delayed-type
hypersensitivity response to the protein antigen,
51BSA, butthatitfailed to inhibitthecutaneous Arthus
vasculitis mediated by antigen, antibody and com-
plement. The latter is particularly noteworthy, since
there is good evidence thatthis vasculitis is triggered
by an anaphylactic reaction involving the release of
vasoactive amines (and possibly platelet activating
factor) from mast cells and basophils sensitized with
homocytropic antibody (3). Thus, the inability ofCT
toblockthe Arthus vasculitis also arguesagainst any
significant inhibition ofbasophil or mast cells by CT
in these studies.
The present demonstration that CTadministration
blocks both the interstitial pneumonitis [associated
with injury by Con A alone (3)] and the immune
complex-associated necrotizing injury supports the
hypothesis that cell-mediated lung injury acts to en-
hance or facilitate immune complex formation in the
lung. Stimulation ofT-lymphocytes appearstobe the
critical initiating event for the following reasons:
Con A is known to directly stimulate T-cells (but not
B-cells) (17); T-lymphocytes are normally present in
the lung (18); Con A has little effect upon mac-
rophages (19); and we have now demonstrated that
inhibition of immune complex lung disease by CT is
associated with inhibition of T-lymphocyte func-
tions, in the absence ofdemonstrable effects on the
immune complex-mediated, basophil/mast cell ini-
tiated Arthus vasculitis.
It should be noted that in some instances the
cutaneous response to Con A and also the produc-
tion of interstitial pneumonitis were only partially
blocked by CT, yet inhibition of immune-complex
injury was striking. Thus, initiation ofimmune com-
plex injury seems dependent upon the extent of
cell-mediated injury produced. Similarly, this find-
ing may also explain the relative inability of BSA
alone to initiate immune complex injury (although
cell-mediated responses to BSA were observed by
the direct active Arthur skin test) since only a small
percentage of bronchoalveolar T-lymphocytes
would theoretically specifically recognize BSA anti-
gen. In contrast, all or most T-lymphocytes should
respond to polyclonal activation by Con A except, of
course, in animals treated with CT.
Demonstrations ofsignicant increases in cAMPin
peripheral lymphocytes from CT-treated animals in-
dicate thatCTisexertingits inhibitory effectsin vivo
through stimulation of intracellular "second mes-
sengers." This finding parallels those changes ob-
served when such cells are treated with CT in vitro
(13, 14), and the 2.7-fold increase observed here
agrees well with the value of 2.1 that Warren and
colleagues observed in mouse spleen cells following
a single injection of CT (16).
In conclusion, these studies call attention to the
possible importance of polyclonal cell activators
which, when present in the environment, may play a
critical role in initiating environmental lung disease.
Such polyclonal activators include not only a vast
array ofplant proteins, including lectins such as that
employed in this study, but also endotoxins, en-
zymes, and even simple inorganic chemicals (20). In
addition, this study additionally emphasizes the im-
portance of regulation, by intracellular mediators
such as cAMP, of immune reactive cells, and in
particulartheirability to respond inthe production of
immune injury. Consideration of such factors may
prove useful in future clinical studies of environ-
mental lung disease, and may facilitate further defi-
nition ofrisk factors both at the individual as well as
environmental level.
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